Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Flerie
Acquired Company
Biosergen
SwedenSwedenBiotechnologyFinancial ServicesHealth CareFinanceVenture CapitalAngel InvestmentMedicalBiotechnologyHealth CareDescription
Flerie AB and Biosergen AB have announced a merger plan, marking Flerie’s first investment since its listing on Nasdaq Stockholm. The merger will result in Biosergen being absorbed by Flerie, with its operations transferred to a new subsidiary. This strategic acquisition aims to foster development of Biosergen's innovative drug candidate BSG005.
Fundz sees it the moment Flerie makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biosergen?
Biosergen was acquired by Flerie, based in Sweden. The deal was reported on June 26, 2026. Flerie AB focuses on developing innovative treatments targeting various medical conditions. The company is engaged in advancing healthcare solutions through strategic mergers. Flerie is privately held and operates in Biotechnology.
When did Flerie acquire Biosergen?
Flerie's acquisition of Biosergen was reported on June 26, 2026. Flerie AB and Biosergen AB have announced a merger plan, marking Flerie’s first investment since its listing on Nasdaq Stockholm. The merger will result in Biosergen being absorbed by Flerie, with its operations transferred to a new subsidiary. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biosergen do?
Biosergen is a biotechnology company focused on developing innovative treatments for fungal infections. The company aims to improve patient outcomes through its specialized therapies. It is privately held, operating in Biotechnology, and is based in Sweden.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.